- Home
- WOLF vs DERM Comparison
WOLF vs DERM Comparison
Compare WOLF & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- DERM
- Stock Information
- Founded
- WOLF 1987
- DERM 2014
- Country
- WOLF United States
- DERM United States
- Employees
- WOLF N/A
- DERM N/A
- Industry
- WOLF Semiconductors
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- WOLF Technology
- DERM Health Care
- Exchange
- WOLF Nasdaq
- DERM Nasdaq
- Market Cap
- WOLF 200.8M
- DERM 165.6M
- IPO Year
- WOLF 1993
- DERM 2021
- Fundamental
- Price
- WOLF $1.25
- DERM $7.01
- Analyst Decision
- WOLF Hold
- DERM Strong Buy
- Analyst Count
- WOLF 10
- DERM 3
- Target Price
- WOLF $8.39
- DERM $12.67
- AVG Volume (30 Days)
- WOLF 7.1M
- DERM 218.8K
- Earning Date
- WOLF 11-05-2025
- DERM 08-12-2025
- Dividend Yield
- WOLF N/A
- DERM N/A
- EPS Growth
- WOLF N/A
- DERM N/A
- EPS
- WOLF N/A
- DERM N/A
- Revenue
- WOLF $757,600,000.00
- DERM $56,397,000.00
- Revenue This Year
- WOLF $15.82
- DERM $28.10
- Revenue Next Year
- WOLF $16.47
- DERM $53.84
- P/E Ratio
- WOLF N/A
- DERM N/A
- Revenue Growth
- WOLF N/A
- DERM N/A
- 52 Week Low
- WOLF $0.39
- DERM $3.54
- 52 Week High
- WOLF $3.33
- DERM $8.90
- Technical
- Relative Strength Index (RSI)
- WOLF 42.72
- DERM 44.38
- Support Level
- WOLF $1.16
- DERM $6.88
- Resistance Level
- WOLF $1.37
- DERM $7.51
- Average True Range (ATR)
- WOLF 0.10
- DERM 0.29
- MACD
- WOLF -0.01
- DERM -0.04
- Stochastic Oscillator
- WOLF 28.33
- DERM 34.83
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.